Today: 21 May 2026
Browse Category

NASDAQ:RZLV 1 October 2025 - 28 March 2026

Rezolve AI (RZLV) stock slips in premarket as Wall Street reopens after holiday

Rezolve AI (RZLV) stock slips in premarket as Wall Street reopens after holiday

Rezolve AI shares fell 0.6% to $4.61 in premarket trading Tuesday after a 30% surge last week on raised revenue guidance and analyst upgrades. A recent SEC filing shows the company expects $350 million in 2026 revenue and faces up to $15 million in settlement payments through May. Shareholders approved new share issuance powers, raising dilution concerns. Broader market sentiment was cautious amid tariff threats.
20 January 2026
·
Rezolve AI PLC stock price jumps: what’s driving RZLV — and what traders watch next

Rezolve AI PLC stock price jumps: what’s driving RZLV — and what traders watch next

Rezolve AI shares closed up 14% at $4.63 after the company set a 2026 revenue goal of about $350 million, more than double prior expectations. Management said December marked its first profitable month and reaffirmed a target of $500 million in annual recurring revenue by end-2026. An audit of 2025 results is underway. Analysts raised price targets but warned execution risks remain.
16 January 2026
·
Rezolve AI PLC (NASDAQ: RZLV) Stock News Today: $200M+ ARR Update Sparks Rally — Forecasts, Analyst Targets, and Key Risks (Dec. 17, 2025)

Rezolve AI PLC (NASDAQ: RZLV) Stock News Today: $200M+ ARR Update Sparks Rally — Forecasts, Analyst Targets, and Key Risks (Dec. 17, 2025)

Rezolve AI PLC expects December 2025 revenue to top $17 million and projects year-end annual recurring revenue above $200 million, according to a December 16 update. The company also anticipates positive adjusted EBITDA for the first time. Shares surged to $2.97, with trading and options volume spiking after the news.
17 December 2025
····
Rezolve AI PLC (RZLV) Stock Skyrockets: The Real Story Behind the Surge (Hint: Rezolve AI)

Rezolve AI PLC (RZLV) Stock Skyrockets: The Real Story Behind the Surge (Hint: Rezolve AI)

Rezolve AI (RZLV) reported H1 2025 revenue of $6.3M, up 426% year-over-year, with gross margin near 96%. Shares surged 24% on Oct. 2 after the company raised its 2025 ARR target to $150M and set a $500M goal for 2026. Multiple analysts upgraded price targets following the results. Market cap stands near $1.4B, but Rezolve remains unprofitable with a high price/sales ratio and tight liquidity.
3 October 2025
···
Rezolve AI Stock Skyrockets on 426% Revenue Surge – Can $7+ Targets Hold?

Rezolve AI Stock Skyrockets on 426% Revenue Surge – Can $7+ Targets Hold?

Rezolve AI (NASDAQ:RZLV) reported H1 2025 revenue of $6.3 million, up 426% year-over-year, beating estimates and raising its 2025 ARR guidance to $150 million. The company completed two Q3 financings totaling $250 million, ending September with $230 million in cash. RZLV shares jumped over 20% pre-market on Oct. 1 after earnings, with analysts raising price targets to $8.50–$9.00.
1 October 2025
···

Stock Market Today

  • CyberTech Systems Earnings Raise Cash Flow Concerns Amid Market Stability
    May 20, 2026, 8:56 PM EDT. CyberTech Systems and Software Limited (NSE:CYBERTECH) posted earnings that met market expectations but revealed an accrual ratio of 0.53, indicating weaker free cash flow relative to profit. This financial metric, which measures non-cash earnings, signals potential challenges for upcoming profits as free cash flow of ₹76 million lagged behind reported profit of ₹304.3 million for the year ending March 2026. Despite a 28% annual growth in earnings per share (EPS) over three years, the decline in cash conversion may raise investor caution. The company's accrual ratio improved last year, suggesting the current shortfall could be temporary, but shareholders are advised to monitor cash flow trends closely against profitability for a clearer outlook.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop